Snowden Capital Advisors’s Medical Properties Trust MPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-265,785
Closed -$2.46M 1139
2023
Q2
$2.46M Buy
265,785
+35,352
+15% +$299K 0.09% 258
2023
Q1
$1.89M Buy
230,433
+73,812
+47% +$815K 0.07% 294
2022
Q4
$1.74M Sell
156,621
-77,996
-33% -$907K 0.07% 310
2022
Q3
$2.78M Buy
234,617
+2,455
+1% +$37.2K 0.13% 200
2022
Q2
$3.54M Sell
232,162
-14,627
-6% -$263K 0.16% 175
2022
Q1
$5.22M Buy
246,789
+13,288
+6% +$286K 0.21% 128
2021
Q4
$5.52M Buy
+233,501
New +$5M 0.28% 94
2021
Q3
Sell
-12,417
Closed -$250K 892
2021
Q2
$250K Buy
12,417
+1,800
+17% +$38.5K 0.01% 773
2021
Q1
$226K Buy
+10,617
New +$228K 0.01% 724

Other funds holding MPT

Snowden Capital Advisors's MPT Position: Q3 2023 in Review

Snowden Capital Advisors sold out of Medical Properties Trust (MPT) in Q3 2023, closing a stake of 265,785 shares — an estimated $2.46M sold.

Snowden Capital Advisors first reported a position in MPT in Q1 2021 and held it in 9 quarters. The position peaked at $5.52M in Q4 2021. 541 funds tracked by Wall St. Rank hold MPT as of Q3 2023.

  • Snowden Capital Advisors reported no remaining Medical Properties Trust position as of Q3 2023 after selling out during the quarter.
  • Snowden Capital Advisors sold 265,785 Medical Properties Trust shares in Q3 2023, an estimated $2.46M.
  • Snowden Capital Advisors first reported a position in Medical Properties Trust in Q1 2021 and held it in 9 quarters.
  • Snowden Capital Advisors's Medical Properties Trust position peaked at $5.52M in Q4 2021.
  • 541 funds tracked by Wall St. Rank held Medical Properties Trust as of Q3 2023.

Based on Snowden Capital Advisors's 13F filing for Q3 2023, filed 14 Nov 2023.